Versant Venture Management, LLC Portfolio Holdings

Versant Venture Management, LLC has filed its 13F form on February 11, 2025 for Q4 2024 where it was disclosed a total value porftolio of $67.6 Million distributed in 7 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Monte Rosa Therapeutics, Inc. with a value of $39.2M, Crispr Therapeutics Ag with a value of $19.6M, Repare Therapeutics Inc. with a value of $3.47M, Tempest Therapeutics, Inc. with a value of $2.95M, and Adverum Biotechnologies, Inc. with a value of $2.37M.

Examining the 13F form we can see an increase of $29.5M in the current position value, from $38.2M to 67.6M.

Versant Venture Management, LLC is based out at San Francisco, CA

Below you can find more details about Versant Venture Management, LLC portfolio as well as his latest detailed transactions.